17-octadecynoic acid

17-octadecynoic acid is a lipid of Fatty Acyls (FA) class. 17-octadecynoic acid is associated with abnormalities such as Renal tubular disorder, Hypertensive disease, abnormal fragmented structure, Blood Clot and Subarachnoid Hemorrhage. The involved functions are known as Hypoxia, Pathological Dilatation, Anabolism, Biochemical Pathway and Stimulus. 17-octadecynoic acid often locates in Endothelium, Muscle, Protoplasm, Microsomes and Membrane. The associated genes with 17-octadecynoic acid are P4HTM gene, EDNRA gene, Gene Family, IMPACT gene and PPP1R1A gene. The related lipids are 17-octadecynoic acid, Fatty Acids, 1-oleoyl-2-acetoyl-sn-glycerol and fatty acid analog.

Cross Reference

Introduction

To understand associated biological information of 17-octadecynoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 17-octadecynoic acid?

17-octadecynoic acid is suspected in Hypertensive disease, Renal tubular disorder, Blood Clot, Subarachnoid Hemorrhage, Renal vascular disorder and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 17-octadecynoic acid

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Hyperthyroidism D006980 12 associated lipids
Cicatrix D002921 9 associated lipids
Glioblastoma D005909 27 associated lipids
Corneal Neovascularization D016510 8 associated lipids
Total 5

PubChem Associated disorders and diseases

What pathways are associated with 17-octadecynoic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 17-octadecynoic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 17-octadecynoic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 17-octadecynoic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 17-octadecynoic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 17-octadecynoic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 17-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 156
Authors Title Published Journal PubMed Link
Miyahara T et al. Cytosolic phospholipase A2 and arachidonic acid metabolites modulate ventilator-induced permeability increases in isolated mouse lungs. 2008 J. Appl. Physiol. pmid:18006865
Jerez S et al. Endothelial dysfunction and improvement of the angiotensin II-reactivity in hypercholesterolemic rabbits: role of cyclooxygenase metabolites. 2008 Eur. J. Pharmacol. pmid:18053983
Zagorac D et al. Antiangiogenic effect of inhibitors of cytochrome P450 on rats with glioblastoma multiforme. 2008 J. Cereb. Blood Flow Metab. pmid:18414496
Wang Z et al. 20-Hydroxyeicosatetraenoic acid inhibits the apoptotic responses in pulmonary artery smooth muscle cells. 2008 Eur. J. Pharmacol. pmid:18455723
Lv X et al. Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion. 2008 Eur. J. Pharmacol. pmid:18771665
Martin BR and Cravatt BF Large-scale profiling of protein palmitoylation in mammalian cells. 2009 Nat. Methods pmid:19137006
Gu RM et al. CYP-omega-hydroxylation-dependent metabolites of arachidonic acid inhibit the basolateral 10 pS chloride channel in the rat thick ascending limb. 2009 Kidney Int. pmid:19641481
pmid:19954757
Ohata H et al. Onset of pulmonary ventilation in fetal sheep produces pial arteriolar constriction dependent on cytochrome p450 omega-hydroxylase activity. 2010 J. Appl. Physiol. pmid:20489034
Weeks T et al. Lipid-cell interactions in human monocytes investigated by doubly-resonant coherent anti-Stokes Raman scattering microscopy. 2011 J Biomed Opt pmid:21361680
Nishimuta H et al. Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans. 2011 Drug Metab. Pharmacokinet. pmid:21383522
Yount JS et al. Bioorthogonal proteomics of 15-hexadecynyloxyacetic acid chemical reporter reveals preferential targeting of fatty acid modified proteins and biosynthetic enzymes. 2012 Bioorg. Med. Chem. pmid:21524915
Ljuca F et al. Contribution of Ras farnesyl transferase, MAP kinase and cytochrome P-450 metabolites to endothelin-1 induced hypertension. 2011 Bosn J Basic Med Sci pmid:21619553
Jerez S et al. 17-Octadecynoic acid improves contractile response to angiotensin II by releasing vasocontrictor prostaglandins. 2012 Prostaglandins Other Lipid Mediat. pmid:21839852
Shao J et al. P-450-dependent epoxygenase pathway of arachidonic acid is involved in myeloma-induced angiogenesis of endothelial cells. 2011 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:22038346
Martin BR et al. Global profiling of dynamic protein palmitoylation. 2012 Nat. Methods pmid:22056678
Li Y et al. DHHC5 protein palmitoylates flotillin-2 and is rapidly degraded on induction of neuronal differentiation in cultured cells. 2012 J. Biol. Chem. pmid:22081607
Adams MN et al. The role of palmitoylation in signalling, cellular trafficking and plasma membrane localization of protease-activated receptor-2. 2011 PLoS ONE pmid:22140500
Singh TU et al. Arachidonic acid inhibits Na⁺-K⁺-ATPase via cytochrome P-450, lipoxygenase and protein kinase C-dependent pathways in sheep pulmonary artery. 2012 Jan-Feb Vascul. Pharmacol. pmid:22155164
Calderon LE et al. iPLA2β overexpression in smooth muscle exacerbates angiotensin II-induced hypertension and vascular remodeling. 2012 PLoS ONE pmid:22363752
Ivaldi C et al. Proteomic analysis of S-acylated proteins in human B cells reveals palmitoylation of the immune regulators CD20 and CD23. 2012 PLoS ONE pmid:22615937
Zoltewicz SJ et al. The palmitoylation state of PMP22 modulates epithelial cell morphology and migration. 2012 ASN Neuro pmid:23127255
Zhai G et al. Inhibition of cytochromes P450 and the hydroxylation of 4-monochlorobiphenyl in whole poplar. 2013 Environ. Sci. Technol. pmid:23320482
Jarrar YB et al. Identification of cytochrome P450s involved in the metabolism of arachidonic acid in human platelets. 2013 Prostaglandins Leukot. Essent. Fatty Acids pmid:23932368
pmid:28698302
Muerhoff AS et al. Prostaglandin and fatty acid omega- and (omega-1)-oxidation in rabbit lung. Acetylenic fatty acid mechanism-based inactivators as specific inhibitors. 1989 J. Biol. Chem. pmid:2910864
Shak S et al. Leukotriene B4 omega-hydroxylase in human polymorphonuclear leukocytes. Suicidal inactivation by acetylenic fatty acids. 1985 J. Biol. Chem. pmid:2997155
Knapp FF et al. Synthesis and evaluation of radioiodinated (E)-18-iodo-17-octadecenoic acid as a model iodoalkenyl fatty acid for myocardial imaging. 1984 J. Med. Chem. pmid:6690690
Zou AP et al. Role of changes in renal hemodynamics and P-450 metabolites of arachidonic acid in the reversal of one-kidney, one clip hypertension. 1995 J. Hypertens. pmid:7561014
Zou AP et al. Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. 1994 Am. J. Physiol. pmid:8141328
Imig JD et al. Cytochrome P-450 inhibitors alter afferent arteriolar responses to elevations in pressure. 1994 Am. J. Physiol. pmid:8203587
Shirane N et al. Cytochrome P450BM-3 (CYP102): regiospecificity of oxidation of omega-unsaturated fatty acids and mechanism-based inactivation. 1993 Biochemistry pmid:8257708
Oyekan AO et al. Relaxant responses of rabbit aorta: influence of cytochrome P450 inhibitors. 1994 J. Pharmacol. Exp. Ther. pmid:8301566
Zou AP et al. Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid omega-hydroxylase, on renal function in rats. 1994 J. Pharmacol. Exp. Ther. pmid:8301590
Gebremedhin D et al. Role of cytochrome P-450 in elevating renal vascular tone in spontaneously hypertensive rats. 1993 Jan-Feb J. Vasc. Res. pmid:8435472
Wang WH et al. Cytochrome P-450 metabolites mediate extracellular Ca(2+)-induced inhibition of apical K+ channels in the TAL. 1996 Am. J. Physiol. pmid:8760035
Imig JD and Navar LG Afferent arteriolar response to arachidonic acid: involvement of metabolic pathways. 1996 Am. J. Physiol. pmid:8760247
Zou AP et al. 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles. 1996 Am. J. Physiol. pmid:8769806
Zygmunt PM et al. Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery. 1996 Br. J. Pharmacol. pmid:8818337
Macica CM et al. Arachidonic acid inhibits activity of cloned renal K+ channel, ROMK1. 1996 Am. J. Physiol. pmid:8853420
Edwards G et al. Effects of cytochrome P450 inhibitors on potassium currents and mechanical activity in rat portal vein. 1996 Br. J. Pharmacol. pmid:8904643
Harder DR et al. Identification of a putative microvascular oxygen sensor. 1996 Circ. Res. pmid:8925569
Lu M et al. Effect of angiotensin II on the apical K+ channel in the thick ascending limb of the rat kidney. 1996 J. Gen. Physiol. pmid:8972391
Grider JS et al. P450 arachidonate metabolites mediate bradykinin-dependent inhibition of NaCl transport in the rat thick ascending limb. 1997 Can. J. Physiol. Pharmacol. pmid:9114929
Carroll MA et al. Cytochrome P450-derived renal HETEs: storage and release. 1997 Kidney Int. pmid:9186856
Van de Voorde J and Vanheel B Influence of cytochrome P-450 inhibitors on endothelium-dependent nitro-L-arginine-resistant relaxation and cromakalim-induced relaxation in rat mesenteric arteries. 1997 J. Cardiovasc. Pharmacol. pmid:9234666
Uddin MR et al. Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling. 1998 Hypertension pmid:9453310
Ferreri NR et al. Angiotensin II induces TNF production by the thick ascending limb: functional implications. 1998 Am. J. Physiol. pmid:9458834
Widmann MD et al. Cytochrome P-450 pathway in acetylcholine-induced canine coronary microvascular vasodilation in vivo. 1998 Am. J. Physiol. pmid:9458878
Chataigneau T et al. Epoxyeicosatrienoic acids, potassium channel blockers and endothelium-dependent hyperpolarization in the guinea-pig carotid artery. 1998 Br. J. Pharmacol. pmid:9504399